Therapeutic indications

Avelumab is indicated for:

Metastatic Merkel cell carcinoma (MCC)

Population group: both men and women, only adults (18 years old or older)

Avelumab is indicated as monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines